Local HT could contribute to changing tumor vessel perfusion and pO2, through activating HIF-1 and its downstream targets, such as VEGF and pyruvate dehydrogenase kinase 1(PDK1), and modifying tumor cell metabolism signaling pathways [20]. Here, VEGFA is linked to neoplasm.